Microbiota-derived indole ligands act on host receptors such as AhR to regulate epithelial repair, barrier function, and immune homeostasis; meanwhile, the host IDO/TDO–kynurenine axis can be modulated by microbial metabolic activity, contributing to immunosuppression and tumor immune evasion. The gene discussed is IDO1; the disease is neoplasm.